Pearl River Capital, LLC Global Blood Therapeutics, Inc. Transaction History

Pearl River Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$32.46 - $43.42 $267,210 - $357,433	-8,232 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $81,540 - $106,479	-2,094 Reduced 20.28%	8,232 $335,000
Q4 2020 Feb 12, 2021	BUY	$37.65 - $63.77 $388,773 - $658,489	10,326 New	10,326 $447,000
Q3 2019 Nov 08, 2019	SELL	$45.35 - $57.91 $17,096 - $21,832	-377 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$52.6 - $63.29 $19,830 - $23,860	377 New	377 $20,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.